ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Avigan set for approval this month in Japan as coronavirus drug

FDA-approved remdesivir on track for green light as soon as this week

Avigan, developed by a subsidiary of Japan's Fujifilm Holdings, blocks viruses from reproducing within the body. (Photo by Koji Uema)

TOKYO -- Japan looks to approve flu drug Avigan as a coronavirus treatment within the month, Prime Minister Shinzo Abe told reporters Monday, speeding up the process by months.

The drug originally was on track for approval in July or later, but Abe has directed the health ministry to accelerate its review of the drug.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more